17-Jan-2023 | Facts and Factors
According to Facts and Factors, the global musculoskeletal disorders drugs market size was worth around USD 97 billion in 2021 and is predicted to grow to around USD 165 billion by 2030 with a compound annual growth rate (CAGR) of roughly 12.1% between 2022 and 2030.
Musculoskeletal disorders refer to the deteriorating health of the locomotor system in the body which consists of bones, muscles, connectivity tissues, and joints. There are more than 150 diseases associated with musculoskeletal disorders. More often than not, the characteristics of these conditions are defined by persistent pain and restrictions in achieving complete mobility. The dexterity of the body is completely or partially impacted in a patient suffering from any type of musculoskeletal disorder. This greatly affects the ability of the patient to perform normal day-to-day tasks with ease. The pain experienced when suffering from a medical issue is one the most common forms of pain observed in non-cancer patients.
Browse the full “Musculoskeletal Disorders Drugs Market Size, Share, Growth Analysis Report By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Drug Stores, and Others), By Disease Type (Muscle Relaxants, Rheumatoid Arthritis, and Others), By Classification (Generic Drugs, and Branded Drugs), By Administration Route (Parenteral, Oral, and Others), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2030" report at https://www.fnfresearch.com/musculoskeletal-disorders-drugs-market
Musculoskeletal conditions are not just limited to a certain age group and persist throughout the life course of an individual starting from childhood up until old age. The condition may be rare, severe, or less painful depending on various factors, but every person is at risk of contracting some form of musculoskeletal disorder if proper care is neglected. Drugs associated with the treatment of the disorders target body organs or parts like joints, bones, muscles, and other systems or areas. Musculoskeletal problems associated with joints are branched as psoriatic arthritis, osteoarthritis, gout, and rheumatoid arthritis. The ones associated with bones may include osteopenia, osteoporosis, and traumatic fractures. Sarcopenia is generally related to disorders of the muscles.
The global musculoskeletal disorders drugs market growth during the projection period may be attributed to rising alcoholism observed across the globe or a growing population that regularly drinks alcoholic drinks. Even if the drinks are consumed in small quantities, prolonged exposure to such drinks is known to severely impact health. With time, the effect can be observed on the muscles, bones, or peripheral nerves of the body and they stop performing as per standards. Some of the major bone complications associated with regular drinking involve osteonecrosis and traumatic fractures.
Whereas the impact on the muscle can cause rhabdomyolysis and prolonged alcohol abuse is also known to cause proximal myopathy. During the pandemic, alcohol was sold in large numbers. As the number of players in the global alcohol market grows, the accessibility to the drinks is projected to grow simultaneously which will further the revenue of the drugs market. The worst cases are observed in underdeveloped economies where cheap alcohol has resulted in dire consequences with proper healthcare infrastructure.
The global market is anticipated to witness growth restraints due to the lack of skilled professionals in the pharmaceutical business. In developing or low-income economies, there is a dearth of proper educational infrastructure to provide the right courses to aspiring students. This leads to a large percentage of the population being unable to access long or short-term courses in drug development subjects.
The increasing innovation and development may provide growth opportunities whereas the high cost is expected to act as a challenging factor.
Segmental Overview
The global musculoskeletal disorders drugs market is segmented based on distribution channel, disease type, classification, administration route, and region.
Based on disease type, the global market divisions are muscle relaxants, rheumatoid arthritis, and others. In 2021, the global market witnessed the highest growth in the rheumatoid arthritis segment owing to the high number of people affected by the condition. It is an autoimmune and inflammatory disease, where the healthy body cells start attaching to other healthy cells. The condition can occur due to a combination of hormones, genetics, and environmental factors, making it a common condition in the current modern world. More than 1.29 million people in the US are known to suffer from the condition.
Based on the administration route, the global market segments are parenteral, oral, and others. The oral segment registered high growth during 2021, as most of the drugs can be consumed orally in case of non-severe cases. Parenteral routes are mostly used in cases where the patient is not capable enough to consume the medicine orally. More than 60% of the small-molecule drugs in the market across diseases are meant to be taken orally.
Regional Overview
North America is anticipated to register the highest growth in the global musculoskeletal disorders drugs market due to the presence of some of the largest pharmaceutical giants in the US. The regional market growth is positively influenced by the growing number of the older population in the region as well as increasing alcoholism.
As per estimates by the World Health Organization (WHO), currently, the world has more than 2.3 billion alcohol drinkers. It is consumed by more than 50% of the population in Europe, the US, and the western parts of the Pacific. Growth in Asia-Pacific may be driven by the growing investments in the healthcare sector and the large market for generic medicines making quality medical care available to a large section of its growing population.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 97 Billion |
Projected Market Size in 2030 |
USD 165 Billion |
CAGR Growth Rate |
12.1% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2030 |
Key Market Players |
Eli Lilly And Company, Mitsubishi Tanabe Pharma Corporation, Sanofi S.A, Bristol-Myers Squibb, Procter & Gamble, Horizon Therapeutics plc, Sino Biopharmaceutical., Pfizer Inc., and others. |
Key Segment |
By Distribution Channel, Disease Type, Classification, Administration Route, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Competitive Analysis:
The global musculoskeletal disorders drugs market is home to players like Eli Lilly And Company, Mitsubishi Tanabe Pharma Corporation, Sanofi S.A, Bristol-Myers Squibb, Procter & Gamble, Horizon Therapeutics plc, Sino Biopharmaceutical., and Pfizer Inc.
Recent Developments:
- In September 2021, Solera Healthcare announced the launch of next-generation therapy solutions for musculoskeletal disorders
- In April 2019, the US Food and Drugs Administration approved the use of Evenity to treat osteoporosis amongst women in the postmenopausal state with high-risk bone fracture
The global methyl methacrylate market is segmented as follows:
By Application
- Constructions
- Automotive
- Electronics
- Healthcare
- Others
By Type
- Ethylene Method
- Acetone Cyanohydrin Method
- Isobutylene Method
- Others
By Region
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1 (347) 690-0211
Email: [email protected]
Web: https://www.fnfresearch.com
